Q5122 is a valid 2023 HCPCS Code that could be used to indicate Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg for reimbursement purposes.
Q5122 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2021.
Inj, nyvepria
Q5122 code information
| HCPCS code: | Q5122 |
| Description: | INJECTION, PEGFILGRASTIM-APGF, BIOSIMILAR, (NYVEPRIA), 0.5 MG |
| Effective Date: | Jan 01, 2021 |
| Added Date: | Jan 01, 2021 |
| Termination Date: | HCPCS Q5122 was terminated on Nov 30, -0001 |
| Pricing indicator: | 53 - STATUTE |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | C - CARRIER JUDGMENT |
| BETOS code: | O1E - OTHER DRUGS |
| Action code: | A - ADD PROCEDURE OR MODIFIER CODE |
| Type of Service: |
1 - MEDICAL CARE
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to Q5122